Name | Number of supported studies | Average coverage | |
---|---|---|---|
mesothelial cell | 6 studies | 44% ± 9% |
Insufficient scRNA-seq data for expression of HAS1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1842.90 | 180 / 180 | 22% | 1.13 | 95 / 430 |
brain | 81% | 175.95 | 2127 / 2642 | 30% | 0.99 | 208 / 705 |
skin | 91% | 567.51 | 1650 / 1809 | 17% | 1.38 | 82 / 472 |
lung | 54% | 351.59 | 311 / 578 | 27% | 1.28 | 311 / 1155 |
intestine | 50% | 187.70 | 485 / 966 | 22% | 2.61 | 117 / 527 |
bladder | 43% | 331.33 | 9 / 21 | 28% | 2.28 | 141 / 504 |
adipose | 70% | 2156.51 | 840 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 36% | 133.56 | 527 / 1445 | 30% | 1.26 | 54 / 183 |
stomach | 33% | 131.22 | 118 / 359 | 29% | 1.21 | 82 / 286 |
pancreas | 5% | 6.72 | 17 / 328 | 56% | 6.24 | 100 / 178 |
breast | 30% | 102.21 | 137 / 459 | 30% | 1.42 | 338 / 1118 |
heart | 56% | 377.14 | 483 / 861 | 0% | 0 | 0 / 0 |
uterus | 25% | 63.56 | 42 / 170 | 20% | 2.63 | 94 / 459 |
blood vessel | 44% | 241.94 | 587 / 1335 | 0% | 0 | 0 / 0 |
thymus | 27% | 63.06 | 177 / 653 | 14% | 1.28 | 85 / 605 |
peripheral blood | 23% | 37.60 | 211 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 1.13 | 6 / 29 |
adrenal gland | 7% | 7.26 | 18 / 258 | 12% | 4.68 | 27 / 230 |
liver | 3% | 3.95 | 6 / 226 | 14% | 0.60 | 57 / 406 |
spleen | 11% | 13.04 | 27 / 241 | 0% | 0 | 0 / 0 |
prostate | 7% | 19.06 | 17 / 245 | 2% | 0.07 | 10 / 502 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.13 | 4 / 45 |
kidney | 2% | 3.67 | 2 / 89 | 5% | 0.19 | 49 / 901 |
muscle | 3% | 6.37 | 27 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030213 | Biological process | hyaluronan biosynthetic process |
GO_0007155 | Biological process | cell adhesion |
GO_0045226 | Biological process | extracellular polysaccharide biosynthetic process |
GO_0010764 | Biological process | negative regulation of fibroblast migration |
GO_0085029 | Biological process | extracellular matrix assembly |
GO_0036120 | Biological process | cellular response to platelet-derived growth factor stimulus |
GO_0006024 | Biological process | glycosaminoglycan biosynthetic process |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0050501 | Molecular function | hyaluronan synthase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | HAS1 |
Protein name | hyaluronan synthase (EC 2.4.1.212) Hyaluronan synthase 1 Hyaluronan synthase 1 (EC 2.4.1.212) (Hyaluronate synthase 1) (Hyaluronic acid synthase 1) (HA synthase 1) (HuHAS1) |
Synonyms | hCG_91965 HAS |
Description | FUNCTION: Catalyzes the addition of GlcNAc or GlcUA monosaccharides to the nascent hyaluronan polymer. Therefore, it is essential to hyaluronan synthesis a major component of most extracellular matrices that has a structural role in tissues architectures and regulates cell adhesion, migration and differentiation. This is one of the isozymes catalyzing that reaction. Also able to catalyze the synthesis of chito-oligosaccharide depending on the substrate (By similarity). . |
Accessions | G3V1S7 M0R2V0 ENST00000601667.5 M0QXH4 ENST00000601714.5 D2N2G5 M0R1L3 ENST00000594621.1 ENST00000540069.7 Q8IYH3 ENST00000222115.5 Q92839 |